ES535289A0 - Procedimiento para preparar 3-(piperidinil)- y 3-(pirrolidinil)-1h-indazoles - Google Patents

Procedimiento para preparar 3-(piperidinil)- y 3-(pirrolidinil)-1h-indazoles

Info

Publication number
ES535289A0
ES535289A0 ES535289A ES535289A ES535289A0 ES 535289 A0 ES535289 A0 ES 535289A0 ES 535289 A ES535289 A ES 535289A ES 535289 A ES535289 A ES 535289A ES 535289 A0 ES535289 A0 ES 535289A0
Authority
ES
Spain
Prior art keywords
indazoles
pirrolidinil
piperidinil
prepare
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535289A
Other languages
English (en)
Other versions
ES8601964A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES8601964A1 publication Critical patent/ES8601964A1/es
Publication of ES535289A0 publication Critical patent/ES535289A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES535289A 1983-08-22 1984-08-20 Procedimiento para preparar 3-(piperidinil)- y 3-(pirrolidinil)-1h-indazoles Granted ES535289A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52508883A 1983-08-22 1983-08-22

Publications (2)

Publication Number Publication Date
ES8601964A1 ES8601964A1 (es) 1985-11-01
ES535289A0 true ES535289A0 (es) 1985-11-01

Family

ID=24091865

Family Applications (2)

Application Number Title Priority Date Filing Date
ES535289A Granted ES535289A0 (es) 1983-08-22 1984-08-20 Procedimiento para preparar 3-(piperidinil)- y 3-(pirrolidinil)-1h-indazoles
ES543206A Expired ES8603867A1 (es) 1983-08-22 1985-05-16 Procedimiento para preparar 3-(piperidinil)- y 3-(pirrolidi-nil) -1h-indazoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES543206A Expired ES8603867A1 (es) 1983-08-22 1985-05-16 Procedimiento para preparar 3-(piperidinil)- y 3-(pirrolidi-nil) -1h-indazoles

Country Status (17)

Country Link
EP (1) EP0135781B1 (es)
JP (1) JPS60100573A (es)
KR (1) KR880002356B1 (es)
AT (1) ATE47139T1 (es)
AU (1) AU575846B2 (es)
CA (1) CA1292232C (es)
DE (1) DE3480091D1 (es)
DK (1) DK400284A (es)
ES (2) ES535289A0 (es)
FI (1) FI82242C (es)
GR (1) GR80160B (es)
HU (1) HU198036B (es)
IL (1) IL72743A (es)
NZ (1) NZ209279A (es)
PH (1) PH22032A (es)
PT (1) PT79110B (es)
ZA (1) ZA846485B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181793B1 (fr) * 1984-10-16 1988-07-27 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique
EP0192935B1 (en) * 1985-01-23 1991-02-27 Hoechst-Roussel Pharmaceuticals Incorporated 3-(piperidinyl)-1h-indazoles a process for their preparation and their use as medicaments
US4999356A (en) * 1987-08-07 1991-03-12 Hoechst-Roussel Pharmaceuticals, Inc. 1-phenyl-3-(1-piperazinyl)-1H-indazoles
GB8811299D0 (en) * 1988-05-12 1988-06-15 Grayshan R Indazole derivatives
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US5015740A (en) * 1988-08-05 1991-05-14 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
IL90879A0 (en) * 1988-09-02 1990-02-09 Janssen Pharmaceutica Nv 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5561128A (en) * 1989-05-19 1996-10-01 Hoechst-Roussel Pharmaceuticals, Inc. N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
DE69021645T2 (de) * 1989-05-19 1996-02-22 Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J. N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater
US5051430A (en) * 1990-09-10 1991-09-24 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1H-indazol-3-yl)-4-pyridinamines
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK55192D0 (da) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindenderivater
WO1994010162A1 (en) * 1992-10-23 1994-05-11 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands
ES2133416T3 (es) * 1992-10-23 1999-09-16 Merck Sharp & Dohme Ligandos de subtipos de receptores de dopamina.
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
US5668148A (en) * 1995-04-20 1997-09-16 Merck & Co., Inc. Alpha1a adrenergic receptor antagonists
US6166027A (en) 1996-10-14 2000-12-26 Bayer Aktiengesellschaft Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases
FR2767827A1 (fr) * 1997-09-03 1999-02-26 Adir Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IL126745A (en) * 1997-11-04 2003-09-17 Pfizer Prod Inc Methods of preparing 4-cyano-4- (substituted indazole) cyclohexanecarboxylic acids useful as pde4 inhibitors
US6133290A (en) * 1998-07-31 2000-10-17 Eli Lilly And Company 5-HT1F agonists
JPWO2004069828A1 (ja) * 2003-02-04 2006-05-25 三菱ウェルファーマ株式会社 ピペリジン化合物およびその医薬用途
CA2551346A1 (en) * 2003-12-31 2005-07-21 Warner-Lambert Company Llc N-substituted piperidine and piperazine derivatives
BRPI0518693A2 (pt) 2004-11-29 2008-12-02 Warner Lambert Co pirazol [3,4-b]piridinas e indazàis terapÊuticos, bem como composiÇço farmacÊutica e uso dos mesmos
JP5749169B2 (ja) * 2008-10-14 2015-07-15 アストラゼネカ アクチボラグ 細菌感染の処置用の縮合スピロ環式ヘテロ芳香族化合物
SI2790687T1 (sl) 2011-12-16 2019-01-31 Poseida Therapeutics, Inc. TRPC4 modulatorji za uporabo pri zdravljenju ali preprečevanju bolečine
JP2015214492A (ja) * 2012-09-07 2015-12-03 大日本住友製薬株式会社 3−(4−ピペリジル)−インダゾール誘導体
EP3609883B1 (en) * 2017-04-11 2022-06-29 Sunshine Lake Pharma Co., Ltd. Fluorine-substituted indazole compounds and uses thereof

Also Published As

Publication number Publication date
HU198036B (en) 1989-07-28
FI82242B (fi) 1990-10-31
EP0135781B1 (en) 1989-10-11
FI843281A (fi) 1985-02-23
GR80160B (en) 1984-12-19
IL72743A0 (en) 1984-11-30
AU575846B2 (en) 1988-08-11
PT79110A (en) 1984-09-01
DE3480091D1 (en) 1989-11-16
PH22032A (en) 1988-05-13
AU3225084A (en) 1985-02-28
FI82242C (fi) 1991-02-11
NZ209279A (en) 1988-05-30
ES543206A0 (es) 1986-01-01
ES8603867A1 (es) 1986-01-01
EP0135781A1 (en) 1985-04-03
ZA846485B (en) 1985-03-27
JPH051792B2 (es) 1993-01-11
DK400284D0 (da) 1984-08-21
FI843281A0 (fi) 1984-08-20
KR850001748A (ko) 1985-04-01
KR880002356B1 (ko) 1988-10-29
ES8601964A1 (es) 1985-11-01
ATE47139T1 (de) 1989-10-15
DK400284A (da) 1985-02-23
JPS60100573A (ja) 1985-06-04
PT79110B (en) 1986-09-15
HUT37139A (en) 1985-11-28
IL72743A (en) 1989-01-31
CA1292232C (en) 1991-11-19

Similar Documents

Publication Publication Date Title
ES535289A0 (es) Procedimiento para preparar 3-(piperidinil)- y 3-(pirrolidinil)-1h-indazoles
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
AT361637B (de) Verfahren zur bekaempfung von mikroorganismen und mittel zur durchfuehrung des verfahrens
GB2058863B (en) Hair treating composition
IE822684L (en) 3-(4-piperidyl)-1,2-benzoxazoles.
GR78402B (es)
DE3381909D1 (de) Phthalazin substituierte aminomethylbenzolabkoemmlinge, zusammensetzungen und verwendung.
DE69004037D1 (de) Apparat zur Wärmebehandlung von kontaminiertem, stückigem Material.
JPS57123926A (en) Steel heat treatment
JPS5780316A (en) Injury healing promoting composition
JPS53121939A (en) Novel treating composition
DE3887970D1 (de) Zusammensetzung zum Behandeln von Textilien.
DE3671006D1 (de) Zusammensetzung zum binden von mineralfasern und so erhaltene mineralfasern.
AT372984B (de) Schnellarbeitsstahl, sowie seine verwendung und waermebehandlung
GB2054373B (en) Pharmaceutical composition for treating gastro-duodenal ulcers
GB2167958B (en) Compositions for treating the scalp.
DE3582484D1 (de) Verfahren zur herstellung von benzylierten phenolen, dibenzylphenolverbindungen und die verwendung solcher phenole als antioxidantien.
DE3262377D1 (en) Novel nitrosourea derivative, process for preparing same and therapeutic composition containing said derivate
IT1188647B (it) Metodo per conservare pellami,pelli e pellicce grezzi
ES8505363A1 (es) Un procedimiento para preparar una 3-(2-furoil)-5-2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridina
DE3576332D1 (de) Stickstoff-verbindungen, ihre herstellung und verwendung als ausgangsprodukte zur herstellung von decalinketonen.
AU2862584A (en) Durchflussmengenmessgerat fur gase und verwendung desselben
ZA815098B (en) Novel arylamine derivatives,production thereof and use thereof as microbicides
IE802247L (en) Hair treatment composition
DD137180A1 (de) Mischung zur bekaempfung von schaedlingen und mikroorganismen

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303